Glofitamab for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma. Shimazu Y, Shimazu Y. J Clin Oncol 2025 Feb 14:JCO2402259. doi: 10.1200/JCO-24-02259.

Read + Share

Amedeo Smart

Independent Medical Education

Shimazu Y, Shimazu Y. Glofitamab for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma. J Clin Oncol 2025 Feb 14:JCO2402259. doi: 10.1200/JCO-24-02259.
PMID: 39951656